Table 1.
Transdiagnostic criteria for clinical staging of internalising and externalising syndromes emerging in childhood (5–11 years)
| Clinical stage | Disability and functioning | Internalising and/or externalising symptoms |
|---|---|---|
| Stage 0: at-risk—no current symptoms | No impairments | No current symptoms |
| Stage 1a: nonspecific symptoms | Mild to moderate impact on social, educational, physical, and daily living | Mild to moderate severity without specific features indicative of more disabling syndromes |
| Stage 1b: attenuated syndrome | Moderate to severe impact on social, educational, physical, and daily living | Moderate severity with specific symptoms indicative of attenuated syndromes |
| Stage 2: discrete disorder or major syndrome | Severe and ongoing impact on social, educational, physical, and daily living | Meets criteria for internalising and/or externalising disorder |
| Stage 3: persistent, treatment resistant illness | Ongoing impact on social, educational, physical, and daily living lasting at least 2 years or over a 12-month period after entry into psychological, pharmacological, or multidisciplinary intervention | Symptoms lasting at least 2 years, with ≤ 3 months of remission or no improvement at 12 months after entry into psychological, pharmacological, or multidisciplinary intervention |
| Stage 4: severe, persistent, unremitting illness | Evidence of marked deterioration in social, educational, physical, and daily living due to persistence illness | Chronic symptoms lasting at least 5 years or no improvement after 2 years after entry into psychological, pharmacological, or multidisciplinary intervention |
Refer to Table 2 for Stage 0 risk factors